Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Family physicians are the primary health care providers for complex patients such as persons with serious mental illness. The psychiatric needs of these patients could take attention away from management of health problems and from usual health promotion services. For example, Schizophrenia is associated with a higher than normal incidence of diabetes, and first line treatments of Schizophrenia have also been found to increase risk for diabetes. As such, this high-risk group requires targeted diabetes strategies. In London Ontario, services are provided to this high risk mental health population primarily by two community agencies: The Western Ontario Therapeutic Community Hostel (WOTCH) and the Canadian Mental Health Association (CMHA). Accordingly, the goal of this project is to assess how these patients are currently being managed by their family physicians and to pilot a community-based, multidisciplinary diabetes clinic model within this population. If this delivery model proves feasible and effective, family physicians could be assisted by existing community agencies in the management of their patients’ diabetes and patients will receive improved access to this vital multidisciplinary team.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetes Mellitus Schizophrenia Psychotic Disorders |
Procedure: Screening Procedure: Management |
Phase 3 |
| Study Type: | Observational |
| Study Design: | Additional Descriptors: Convenience Sample Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Retrospective/Prospective |
| Official Title: | Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population - An Evaluation Project |
| Enrollment: | 75 |
| Study Start Date: | September 2004 |
| Study Completion Date: | September 2005 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Active in current WOTCH/CMHA database with listed diagnosis of a psychotic disorder an or use of Novel Antipsychotics. Must have Family Physician contact.
Exclusion Criteria:
- any patient with declaration on file stating incapable of consenting to treatment.
Contacts and Locations| Canada, Ontario | |
| London Intercommunity Health Centre | |
| London, Ontario, Canada, N5W 2Z1 | |
| Principal Investigator: | David RS Haslam, MSc MD FRCPC | Regional Mental Health Care, London |
| Principal Investigator: | Stewart B Harris, MD MPH CCFP FACPM | Centre for Studies in Family Medicine |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00253240 History of Changes |
| Other Study ID Numbers: | R-04-441, G13-05457, 10933E, LRI7760576 |
| Study First Received: | November 10, 2005 |
| Last Updated: | July 20, 2007 |
| Health Authority: | Canada: Health Canada |
Additional relevant MeSH terms:
|
Diabetes Mellitus Psychotic Disorders Mental Disorders Schizophrenia |
Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on May 23, 2013